ELIOS: A multicentre, molecular profiling study of patients (pts) with epidermal growth factor receptor-mutated (EGFRm) advanced NSCLC treated with first-line (1L) osimertinib

Z. Piotrowska; M-J. Ahn; Y-K. Pang; S.H. How; K. Sang-We; P.J. Voon; D.L. Cortinovis; J. De Castro Carpeno; M. Tiseo; D. Rodriguez Abreu; S.S. Ramalingam; J. Li; L. Servidio; S. Sadow; R.J. Hartmaier; B.C. Cho

doi:10.1016/j.annonc.2022.10.398

YUHSpace

BROWSE

0 154

Cited 0 times in

ELIOS: A multicentre, molecular profiling study of patients (pts) with epidermal growth factor receptor-mutated (EGFRm) advanced NSCLC treated with first-line (1L) osimertinib

Authors: Z. Piotrowska ; M-J. Ahn ; Y-K. Pang ; S.H. How ; K. Sang-We ; P.J. Voon ; D.L. Cortinovis ; J. De Castro Carpeno ; M. Tiseo ; D. Rodriguez Abreu ; S.S. Ramalingam ; J. Li ; L. Servidio ; S. Sadow ; R.J. Hartmaier ; B.C. Cho